Randomized, double-blind, placebo-controlled phase II study of AMG 386 in combination with cisplatin and capecitabine (CX) in patients (pts) with metastatic gastroesophageal adenocarcinoma.
Martin M. Eatock
Disclosure not yet available
Janos Szanto
Disclosure not yet available
Niall C. Tebbutt
Disclosure not yet available
Carolyn L. Bampton
Disclosure not yet available
Andrew H. Strickland
Disclosure not yet available
Manuel Valladares Ayerbes
Disclosure not yet available
Nuwan Nanayakkara
Disclosure not yet available
Yu-Nien Sun
Disclosure not yet available
Adeboye H. Adewoye
Disclosure not yet available
Gyorgy Bodoky
Disclosure not yet available